![Mihael Polymeropoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mihael Polymeropoulos
Vorstandsvorsitzender bei
VANDA PHARMACEUTICALS INC.
Vermögen: 10 Mio $ am 31.05.2026
Profil
Mihael Hristos Polymeropoulos is the founder of Vanda Pharmaceuticals, Inc., founded in 2002.
Titles held at Vanda Pharmaceuticals, Inc. include Chairman, President & Chief Executive Officer since 2021.
Dr. Polymeropoulos is also the founder of Integrated Molecular Analysis of Genome Expression.
Former jobs include VP & Head-Pharmacogenetics Department at Novartis AG from 1998 to 2003 and Chief-Gene Mapping Section at National Human Genome Research Institute from 1992 to 1998.
Education includes undergraduate studies at the University of Patras.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2026 | 1.588.246 ( 2,64 % ) | 10 Mio $ | 31.05.2026 |
Aktive Positionen von Mihael Polymeropoulos
| Unternehmen | Position | Beginn |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Vorstandsvorsitzender | 01.05.2003 |
Ehemalige bekannte Positionen von Mihael Polymeropoulos
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.01.2003 |
National Human Genome Research Institute
 National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Corporate Officer/Principal | 01.01.1998 |
Integrated Molecular Analysis of Genome Expression | Gründer | - |
Ausbildung von Mihael Polymeropoulos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Patras
 University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Integrated Molecular Analysis of Genome Expression | |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Government |
